Лучевая терапия супратенториальных глиом головного мозга

V. D. Rozumenko; D. A. Lazar; S. V. Tyagly

Authors

V. D. Rozumenko Romodanov Neurosurgery Institute, Kiev, Ukraine https://orcid.org/0000-0002-8774-6942
D. A. Lazar National Medical Academy of Postgraduate Education named after P.L. Shupyk of Ministry of Health Care of Ukraine, Kiev, Ukraine
S. V. Tyagly Zaporozhye State Medical University, Zaporozhye, Ukraine

Keywords:

глиомы головного мозга, лучевая терапия, доза облучения.

Abstract

Article dedicates to possibility and efficient radiation therapy of supratentorial gliomas. There are the results of 202 patients’ treatment. With literature basis and our practice it has been analyses of different methods of radiomodification in radiotherapy. Recommended methods of “space-time” dose distribution wish can use in clinical practice of radiotherapeutistes.

References

Барабой В.А., Зинченко В.А. Вторичная радиорезистентность опухолевых клеток и пути ее преодоления // Журн. АМН України. — 1999. — Т.5, № 3. — С. 453—469.

Зозуля Ю.А., Розуменко В.Д., Лисяный Н.И. Проблемы современной нейроонкологии // Журн. АМН України. — 1999. — Т.5, №3. — С.426—441.

Иванов В.К. Математическое моделирование и оптимизация лучевой терапии. — М., 1986. — С.20—22.

Марченко С.В. Комплексное лечение злокачественных глиом больших полушарий большого мозга // Вопр. онкологии. — 1997. — Т.43, №8. — С.610—612.

Розуменко В.Д. Бор-нейтронзахватная терапия опухолей головного мозга (обзор лит.) // Укр. нейрохірург. журн. — 2001. — №3. — С.4—12.

Розуменко В.Д., Главацький О.Я., Хмельницький Г.В. Гліоми головного мозку: діагностика, лікування та прогнозування його результатів. Сучасний стан проблеми // Онкология. — 2000. — Т.2, №4. — С.275—281.

Савченко А.Ю., Новиков В.П., Левочко Е.Д. Комбинированное лечение опухолей головного мозга нейроэктодермального происхождения // Вестн. рентгенол. радиол. — 1966. — №4. — С.141—148.

Alheit H., Dornfeld S., Dawel M. et al. Patient position reproducibility in fractionated stereotactically guided conformal radiotherapy using the BrainLab mask System // Strahlenther Onkol. — 2001. — V.177, №5. — P.264—268.

Barth R. F., Soloway A.H., Brugger R.M. Boron neutron capture therapy of brain tumors: past history,current status and future potential // Cancer Invest. — 1996. — V.14, №6. — P.534—550.

Benesch M., Lackner H., Moser A. et al. Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas // Pediatr. Neurosurg. — 2001. — V.35, №4. — P.173—180.

Bernstein J.J., Goldberg W.J., Laws E.R. C6 glioma cells invasion and migration of rat brain after neural homografting: Ultrastructure // Neurosurg. — 1990. — V. 26. — P. 622-628.

Devaux B.C., O-Fallon J.R., Kelly P.J. Rsection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome // J. Neurosurg. — 1993. — V.78, №5. — P.767—775.

Do V., Gebski V., Barton M.B. The effect of waiting for radiotherapy for grade III/IV gliomas // Radiother. Oncol. — 2000.—V.57, №2. — P.131—136.

Engstrom P.E., Persson B.R., Brun A., Salford L.G. A new antitumour treatment combining radiation and electric pulse // Anticancer Res. — 2001. — №3. — P.1809—1815.

Forsyth P.A., Roa W.H. Primary central nervous system tumors in adults // Curr. Treat. Options Neurol. — 1999. — V.1, №5. — P.377—394.

Grabenbauer G.G., Roedel C.M., Paulus W., Ganslandt O., Schuchardt U., Buchfelder M., Schrell U., Fahlbusch R., Huk W.J., Sauer R. Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy // Strahlenther Oncol. — 2000. — V. 176, № 6. — P.259-264.

Grana C., Chinol M., Robertson C. et al. Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study // Br. J. Cancer. — 2002. — V.86, №2. — P.207—212.

Henriksson R., Persson L. BNCT — neutron radiotherapy of brain tumors // Lakartidningen. — 2002. — V.99, №4. — P.289—290.

Hug E.B., Muenter M.W., Archambeau J.O. et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas // Strahlenther Onkol. — 2002. — V.178, №1. — P.10—17.

Huncharek M., Muscat J. Treatment of recurrent high grade astrocytoma: results of a systematic review of 1415 patients // Anticancer. Res. — 1998. — V.18. — P.1303—1311.

Jeremic B., Bamberg M. Radiation therapy for incompletely resected supratentorial low-grade glioma in adults // J. Neurooncol. — 2001. — V.55, №2. — P.101—112.

Kim I.A., Yang Y.J., Yoon S.C. et al. // Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas // Int. J. Oncol. — 2001. — V.19, №5. — P1041—1047.

Kondziolka D., Flickinger J.C., Bissonette D.J., Bozik M., Lusford L.D. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms // Neurosurgery. — 1997. — V.41, №4. — P.776—785.

Kreth F.W., Warnke P.C., Scheremet R., Ostertag C.B. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme // J. Neurosurg. — 1993. — V.78, №5. — P.762—766.

Langer C.J., Ruffer J., Rhodes H. et al. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme // Int. J. Radiat. Oncol. Biol. Phys. — 2001. — V.51, №1. — P.113—119.

Legler J., Ries L., Smith M. et al. Brain and other central nervous system cancers: recent trends in incidence and mortality // J. Nat. Cancer Inst. — 1999. — V.91, №16.

Leighton G., Fisher B., Bauman G. , et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation // J. Clin. Oncol. — V. 15 . — P. 1294—1301.

Levin V.A., Yang W.K., Bruner J. et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas // Int. J. Radiat. Oncol. Biol. Phys. — 2002. — V.53, №1. — P.58—66.

Liu L., Vapiwala N., Munoz L.K. et al. A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors // Med. Pediatr. Oncol. — 2001. — V.37, №4. — P.390—392.

Liu S., Yu X., Guo Y. et al. Interstitial brachytherapy using iridium-192 for malignant brain tumors: clinical results // Chin. Med. J. — 1999. — V. 112, №2. — P.139—142.

Liu Y., Xiao S., Liu M. et al. Analysis of related factors in complications of stereotactic radiosurgery in intracranial tumors // Stereotact. Funct. Neurosurg. — 2000. — V.75, №2—3. — P.129—132.

Loiseau H., Kantor G. The role of surgery in the treatment of glial tumors // Cancer Radiother. — 2000. — V.4, №1. — P.48—52.

Lote K. Survival, prognostic factors, and therapeutic efficacy in low-grade gliomas: a restrospective study of 379 patients // J. Clin. Oncol. — 1997. — V.15, №9. — P.3129—40.

Mansur D.B., Hekmatpanah J., Wollman R., Macdonald L., Nicholas K., Beckmann E., Mundt A.J. Low grade gliomas treated with adjuvant radiation therapy in the modern imaging era // Am. J. Clin. Oncol. — 2000. — V.23, №3. — P.222—226.

Matsucado Y., MacCarty C.S.,Kernohan J.W. The growth of glioblastoma multiforme in neurosurgical practice // J. Neurosurg. — 1961. — V.18. — P.636—644.

Nwokedi E.C., DiBiase S.J., Jabbour S. et al. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme // Neurosurgery. — 2002. — V.50, №1. — P.41—46.

Peterson K., Harsh G., Fisher P.G. et al. Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma // J. Neurooncol. — 2001. — V.5, №1. — P.27—32.

Phuphanich S., Ferrall S., Greenberg H. Long-term survival in malignant glioma. Prognostic factors // J. Fla. Med. Assoc. — 1993. — V.80, № 3. — P.181—184.

Quigley M.R., Flores N., Maroon J.C., Sargent B., Lang S., Elrifai A. Value of surgical intervention in the treatment of glioma // Stereotact. Funct. Neurosurg. — 1995. — V. 65, №1—4. — P.171—175.

Radek A., Grochal M., Gasinski P. et al. Stereotactic biopsy and brachytherapy in the diagnostics and treatment of brain tumors, preliminary report // Neurol. Neurochir. Pol. — 2001. — V.35. — Suppl. 5. — P.5—11.

Salminen E., Nuutinen J.M., Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma // Eur. J. Cancer. — 1996. — V.32A, №11. — P.1918—1923.

Saran F.H., Baumert B.G., Khoo V.S. et al. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood // Int. J. Radiat. Oncol. Biol. Phys. — 2002. — V.53, — №1. — P.43—51.

Schonecaes K., Mucke R., Panke J. et al. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma // Tumori. — 2002. — V.88, №1. — P.28—31.

Tola M.R., Casetta I., Granieri E., Piana L., Veronesi V., Tamarozzi R., Trapella G., Monetti V.C., Paolino E., Govoni V. et al. Intracranil gliomas in Ferrara, italy, 1976 to 1991 // Acta Neurol. Scand. — 1994. — V.90, №5. — P.312—317.

Ushio Y., Kochi M. Prognostic factors in malignant gliomas // Gan To Kagaku Ryoho. — 1996. — V.23, №5. — P.643—648.

Videtic G.M., Gaspar L.E., Zamorano L. et al. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis // Int. J. Radiat. Oncol. Biol. Phys. — 2001. — V.51, №4. — P.963—968.

Villavicencio A.T., Black P.M., Shrieve D.C., Fallon M.P., Alexander E., Loeffler J.S. Linac radiotherapy for skull base meningeomas // Acta Neurochir. — 2001. — V.143, №11. — P.1141—1152.

Voges J., Treuer H., Schlegel W., Pastyr O., Sturm V. Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds // Acta Neurochir. Suppl (Wien). — 1993. — V.58. — P.108—111.

Weil M.D. Advances in stereotactic radiosurgery for brain neoplasms // Curr. Neurol. Neurosci. Rep. — 2001. — №3. — P.233—237.

Williams J. Stereotactic radiosurgery for human glioma: treatment parameters and outcome for low vs.high grade // J. Radiosurgery. — 1998. — V.1. — P.3—8.

Year 2000 Standard Statistical Report // Central Brain Tumor Registry of the United States, 1999. — P.7—18.